Allogene Therapeutics (ALLO) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.33
-0.28
-0.24
-0.19

Details

Expected EPS
-0.218435
Actual EPS
-0.19
Surprise EPS
0.03
Surprise Percent
+13.02%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.19 per share for Q4 2025.

0 Comments

Share your thoughts